Sandra Demaria

Translational tumor immunologist, breast cancer pathologist, passionate about cancer immunotherapy

[Sandra Demaria @DemariaLab_WCM]

This account is not active. You can find me
@sandrademarialab.bsky.social

[CaixaResearch @CaixaResearch]

¿Cómo avanzarán las inmunoterapias contra el c��ncer de mama en los próximos 1⃣0⃣ años?

🔬 @deVisserKarin, @DemariaLab_WCM y @Casanova_Acebes nos traen algunas claves de lo hablado hace unos días en el @CNIOStopCancer-#CaixaResearch Frontiers Meeting.👇

https://t.co/X9qTRBmo4H

[Sandra Demaria @DemariaLab_WCM]

Join the SITC Run Club for the 2025 AACR Runners for Research 5K Run/Walk in support of Cancer Research! https://t.co/UWhiEm2AGx via @DonorDrive
@gulleyj1
@JennGuerriero

[Sandra Demaria @DemariaLab_WCM]

@FaltasLab @CD_AACR @Nature Congratulations on the beautiful work!

[Sandra Demaria @DemariaLab_WCM]

Happy to be recognized by
@Clarivate as a 2024 Highly Cited Researcher who has demonstrated significant influence in their field!
#HighlyCited2024
https://t.co/ha8ZTHTJZU

[Kristopher Sarosiek @CellDeathLab]

➡️Join us October 11th at the JBL Symposium to hear from leaders in radiation oncology and AI in medicine including
@HugoAerts (@harvardmed)
@DrRebeccaHowel1 (@MDAndersonNews)
@DemariaLab_WCM (@WeillCornell) &
@HenningWillers (@MGHCancerCenter)!
Info: https://t.co/00E3XV6wPZ

[Journal for ImmunoTherapy of Cancer @jitcancer]

September @sitcancer #JITC Reading List by Section Editor Sandra Demaria @DemariaLab_WCM @WeillCornell selection #4: FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment by @RockefellerUniv and @ChilesResearch https://t.co/EENt6YcUzi

[Immunorad @immunorad]

Jalal Ahmed presented exciting insights into enhancing CAR T cell therapy in solid tumors in the last talk of this "Novel Approaches" session. His talk focused on how radiotherapy (RT) can improve the effectiveness of CAR T cells in solid tumors.

[Immunorad @immunorad]

🗺 To finish this second day of the Immunorad conference, Brian D. Brown presented exciting research on how tumor microenvironment (TME) composition impacts immunotherapy (IO) success.

[Immunorad @immunorad]

Dr. Sierra McDonald presented complementary findings from the P-RAD clinical trial and a genetically engineered TNBC mouse model:

[Immunorad @immunorad]

⭐ Exciting takeaways from Anguraj Sadanandam, Ph.D.'s talk on AI and single-cell data analysis. He began by discussing the challenges of data-driven algorithms, emphasizing that cancer evolution is multifactorial and requires diverse data inputs.

[Immunorad @immunorad]

Timothy Chan kicked off the "Cancer Immunogenomics and Radiation Therapy" session with a detailed talk emphasizing the need for biomarker identification to improve the efficacy of RT/IO combinations.

[Immunorad @immunorad]

⌚️To finish this session, Sean Pitroda presented extensive research on “Immunogenomic Responses to Combination SBRT and Immune Checkpoint Blockade in Metastatic NSCLC.” , from a recently published work originally from COSINR randomized phase I trial.

[Immunorad @immunorad]

Exciting updates from Gaorav Gupta on the P-RAD trial—the first randomized study comparing aPD-1 alone vs. aPD-1 + RT in early-stage, LN metastatic, TNBC, and high-risk HR-HER2- breast cancer:

[Immunorad @immunorad]

Great insights from Dr. Kristina Young’s talk on targeting TGF-β in rectal cancer, showing that TGF-β directly impact CD8+ T-cells anti-tumor efficacy

[Immunorad @immunorad]

🌟 Exciting Insights from Alan Melcher's talk on T Cell Dynamics and Radiotherapy in Rectal Cancer! 🌟

During his presentation, Prof. Melcher highlighted how a strong immune response to radiotherapy mimics viral infection.

[Immunorad @immunorad]

⭐️Kicking off the second day of ImunoRad, Anne-Gaëlle Goubet presented an exciting talk on leveraging Flash Radiotherapy for immune engagement and tumor control.

[Immunorad @immunorad]

Dr. Ben Chetrit stressed the need for developing innate immune strategies, particularly targeting Notch4 to reverse macrophage-related immunosuppression.

[Immunorad @immunorad]

"Radiation Therapy-Induced Modulation of the Tumor Immune Microenvironment" kicked off with insights from James Welsh on novel strategies to tackle checkpoint resistance.

[Immunorad @immunorad]

📷 Gut-Immune Axis: Healthy gut microbiome dysbiosis can enhance the immune system's ability to fight cancer cells

📷Low-dose #radiation: When combined with specific gut bacteria, can boost the response to immunotherapy and may drive the #abscopal effect. Prospective study inc